Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia

World Journal of Surgical Oncology

Volumn 6, Issue , 2008, Pages

  See, Hui ^a   Yap, Yoke ^a   Yip, Wai ^a   Seow, Heng ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

LATENT MEMBRANE PROTEIN 1; UNCLASSIFIED DRUG; VIRUS PROTEIN; XHO1 PROTEIN; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; MATRIX PROTEIN; PDLIM7 PROTEIN, HUMAN; SIGNAL PEPTIDE; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE; VIRUS DNA;

ARTICLE; CANCER INCIDENCE; CARBOXY TERMINAL SEQUENCE; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENDEMIC DISEASE; EPSTEIN BARR VIRUS; ETHNIC DIFFERENCE; GENE DELETION; GENE LOSS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALAYSIA; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PROGNOSIS; RESTRICTION SITE; SQUAMOUS CELL CARCINOMA; UNDIFFERENTIATED CARCINOMA; BINDING SITE; BLOOD; CHINA; ETHNOLOGY; FEMALE; GENETICS; INCIDENCE; MALE; METABOLISM; MUTATION; NASOPHARYNX TUMOR; NUCLEOTIDE SEQUENCE; PILOT STUDY;

BASE SEQUENCE; BINDING SITES; CHINA; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA, VIRAL; FEMALE; GENE DELETION; HERPESVIRUS 4, HUMAN; HUMANS; INCIDENCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALAYSIA; MALE; MUTATION; NASOPHARYNGEAL NEOPLASMS; PILOT PROJECTS; VARIATION (GENETICS); VIRAL MATRIX PROTEINS;

EID: 40749092346     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-6-18     Document Type: Article

References (41)

1. Wei WI Sham JST Nasopharyngeal carcinoma Lancet 2005, 365:2041-2054 10.1016/S0140-6736(05)66698-6 15950718
2. Chan ATC Teo PML Ngan RK Leung TW Lau WH Zee B Leung SF Cheung FY Yeo W Yiu HH Yu KH Chiu KW Chan DT Mok T Yuen KT Mo F Lai M Kwan WH Choi P Johnson PJ Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Progression-free survival analysis of a phase III randomized trial Journal of clinical oncology 2002, 20(8):2038-2044 10.1200/ JCO.2002.08.149 11956263
3. Lim CCG Yahaya H Second Report of the National Cancer Registry: Cancer incidence in Malaysia 2003 National Cancer Registry, Malaysia 2004
4. Prasad U Nasopharyngeal carcinoma: How to improve survival? The Epstein-Barr virus and associated diseases Montrouge, France, John Libbey Eurotext Ltd Tursz T, Pagano JS, Ablashi DV, De Thé G, Lenoir G, Pearson GR 1993, 717-721
5. Burgos JS Involvement of the Epstein-Barr Virus in the Nasopharyngeal Carcinoma Pathogenesis Medical Oncology 2005, 22:113-121 10.1385/ MO:22:2:113 15965273
6. Pathmanathan R Prasad U Sadler R Flynn K Raab-Traub N Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma The New England Journal of Medicine 1995, 333:693-698 10.1056/NEJM199509143331103 7637746
7. Dawson CW Rickinson AB Young LS Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation Nature 1990, 344:777-780 10.1038/344777a0 2158628
8. Kaye KM Izumi KM Kieff E Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation Proceedings of the National Academy of Sciences USA 1993, 90(19):9150-9154 10.1073/ pnas.90.19.9150 8415670 47519
9. Kieff E Epstein-Barr virus and its replication Fields Virology Philadelphia, Lippincott-Raven Publishers Fields BN, Knipe DM, Howley PM 3 1996, 2343-2396
10. Vera-Sempere FJ Burgos JS Botella MS Cordoba J Gobernado M Immunohistochemical expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1) in paraffin sections of EBV-associated nasopharyngeal carcinoma in Spanish patients Eur J Cancer Part B: Oral Oncology 1996, 32B(3):163-168 10.1016/0964-1955(95)00093-3 8762873
11. Sandvej K Gratama JW Munch M Zhou XG Bolhuis RL Andresen BS Gregersen N Hamilton-Dutoit S Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: Identification of four variants among wild-type EBV isolates Blood 1997, 90:323-330 9207468
12. Li SN Chang YS Liu ST Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus Oncogene 1996, 12(10):2129-2135 8668338
13. Sandvej K Peh SC Andresen B Pallesen G Identification of potential hot-spots in the carboxy-terminal part of the Epstein Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV associated diseases: High frequency of a 30 bp deletion in Malaysian and Danish peripheral T-cell lymphomas Blood 1994, 84:4053-4060 7994023
14. Dolcetti R Zancai P De Re V Gloghini A Bigoni B Pivetta B De Vita S Carbone A Boiocchi M Epstein Barr virus strains with latent membrane protein-1 deletions: Prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease Blood 1997, 89:1723-1731 9057656
15. Chiang AK Wong KY Liang AC Srivastava G Comparative analysis of Epstein-Barr virus gene polymorphisms in nasal T/NK-cell lymphomas and normal nasal tissues: Implications on virus strain selection in malignancy International Journal of Cancer 1999, 80(3):356-364 10.1002/ (SICI)1097-0215(19990129)80:3<356::AID-IJC4>3.0.CO;2-D 9935174
16. Kingma DW Weiss WB Jaffe ES Kumar S Frekko K Raffeld M Epstein-Barr virus latent membrane protein-1 oncogene deletions: Correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas Blood 1996, 88:242-251 8704180
17. Knecht H Bachmann E Brousset P Sandvej K Nadal D Bachmann F Odermatt BF Delsol G Pallesen G Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma Blood 1993, 82:2937-2942 8219183
18. Chen ML Tsai CN Liang CL Shu CH Huang CR Sulitzeanu D Liu ST Chang YS Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population Oncogene 1992, 7(11):2131-2140 1331932
19. Abdel-Hamid M Chen JJ Constantine N Massoud M Raab-Traub N EBV strain variation: Geographical distribution and relation to disease state Virology 1992, 190:168-175 10.1016/0042-6822(92)91202-6 1356286
20. Khanim F Yao QY Niedobitek G Sihota S Rickinson AB Young LS Analysis of Epstein-Barr Virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations Blood 1996, 88:3491-3501 8896415
21. Hu LF Zabarovsky ER Chen F Cao SL Ernberg I Klein G Winberg G Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma Journal of General Virolology 1991, 72:2399-2409
22. Rowe M The EBV latent membrane protein-I (LMPI): A tale of two functions Epstein-Barr Virus Report 1995, 2:99-104
23. Lin JC Lin SC Luppi M Torelli G Mar EC Geographic sequence variation of latent membrane protein 1 gene of Epstein-Barr virus in Hodgkin's lymphomas Journal of Medical Virology 1995, 45(2):183-191 10.1002/ jmv.1890450213 7775937
24. Wu SJ Lay JD Chen CL Chen JY Liu MY Su IJ Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: A comparison with nasopharyngeal carcinoma in an endemic area Journal of Medical Virology 1996, 50(4):314-321 10.1002/ (SICI)1096-9071(199612)50:4<314::AID-JMV6>3.0.CO;2-B 8950688
25. Zhang M Zong YS He JH Zhong BL Lin SX Liang YJ Comparison of the Epstein-Barr virus infection and 30 bp-deleted LMP1 gene among 4 histologic types of nasopharyngeal carcinoma Zhonghua Bing Li Xue Za Zhi 2003, 32(4):342-346 14514380
26. Chang KP Hao SP Lin SY Ueng SH Pai PC Tseng CK Hsueh C Hsieh MS Yu JS Tsang NM The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma Laryngoscope 2006, 116(4):541-546 10.1097/01.mlg.0000201993.53410.40 16585856
27. Tan EL Peh SC Sam CK Analyses of Epstein-Barr virus latent membrane protein-1 in Malaysian nasopharyngeal carcinoma: High prevalence of 30-bp deletion, Xho I polymorphism and evidence of dual infections Journal of Medical Virology 2003, 69:251-257 10.1002/jmv.10282 12683415
28. Plaza G Santon A Vidal AM Bellas C Latent membrane protein-1 oncogene deletions in nasopharyngeal carcinoma in Caucasian patients Acta Otolaryngology 2003, 123(5):664-668 12875592
29. Kim LH Peh SC Epstein-Barr virus-associated lymphomas in Malaysia: High frequency of a 30 bp deletion in the viral latent membrane protein-1 (LMP-1) oncogene Journal of Clinical and Experimental Hematopathology 2003, 43:11-19
30. Peh SC Kim LH Mun KS Tan EL Sam CK Poppema S Epstein-Barr virus (EBV) subtypes and variants in malignant tissue from Malaysian patients Journal of Clinical and Experimental Hematopathology 2003, 43:61-69
31. Sung NS Edwards RH Seillier-Moiseiwitsch F Perkins AG Zeng Y Raab-Traub N Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China International Journal of Cancer 1998, 76(2):207-215 10.1002/ (SICI)1097-0215(19980413)76:2<207::AID-IJC7>3.0.CO;2-0 9537582
32. Chang YS Su IJ Chung PJ Shu CH Ng CK Wu SJ Liu ST Detection of an Epstein-Barr-virus variant in T-cell-lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population International Journal of Cancer 1995, 62(6):673-677 10.1002/ ijc.2910620605 7558413
33. Cheung ST Lo KW Leung SF Chan WY Choi PHK Johnson PJ Lee JCK Huang DP Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong International Journal of Cancer 1996, 66:711-712 10.1002/ (SICI)1097-0215(19960529)66:5<711::AID-IJC21>3.0.CO;2-5
34. Chan AKC Chiu RWK Lo YMD Cell-free nucleic acids in plasma, serum and urine: A new tool in molecular diagnosis Annals of Clinical Biochemistry 2003, 40:122-130 10.1258/000456303763046030 12662399
35. Moorthy RK Thorley-Lawson DA All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts Journal of Virology 1993, 67:1638-1646 237535 8382313
36. Han AJ Zong YS Zhang M Cao SM Lin SX Liang YJ Analysis of Epstein-Barr virus with BamHI "f" variant and XhoI-loss of LMP1 gene in nasopharyngeal carcinoma Chinese Journal of Pathology 2003, 32(6):534-538 14761599
37. Khanim F Yao QY Niedobitek G Sihota S Rickinson AB Young LS Analysis of Epstein-Barr Virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations Blood 1996, 88(9):3491-3501 8896415
38. Jeng KCG Hsu CY Liu MT Chung TT Liu ST Prevalence of Taiwan variant of Epstein-Barr virus in throat washings from patients with head and neck tumors in Taiwan Journal of Clinical Microbiology 1994, 32:28-31 262964 8126200
39. D'Addario M Chauvin P Ethnic differences in theexpression of Epstein-Barr virus latent membrane protein-1 mutations in nasopharyngeal carcinoma Mutation Research 2000, 457(1-2):69-78 11106799
40. Knecht H Bachmann E Brousset P Rothenberger S Einsele H Lestou VS Delsol G Bachmann F Ambros PF Odermatt BF Mutational hotspots within the carboxy terminal region of the LMPl oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders Oncogene 1995, 10523-10528
41. Santon A Manzanal AI Camlo E Bellas C Deletions in the Epstein-Barr virus latent membrane protein-1 oncogene in Hodgkin's disease Journal of Clinical Pathology 1995, 48(4):M184-M187 16696002 407958